'Real-World' Increase in Biomarker Testing in NSCLC

Real-world data from Spain suggest that biomarker testing for patients with advanced non–small cell lung cancer (NSCLC) is finally increasing.
Medscape Medical News

source https://www.medscape.com/viewarticle/971825?src=rss